Network meta-analysis demonstrates the safety of pharmacotherapy for smoking cessation in cardiovascular patients

  title={Network meta-analysis demonstrates the safety of pharmacotherapy for smoking cessation in cardiovascular patients},
  author={A. Pipe},
  journal={Evidence-Based Medicine},
  pages={193 - 193}
  • A. Pipe
  • Published 2014
  • Medicine
  • Evidence-Based Medicine
Commentary on : Mills EJ, Thorlund K, Eapen S, et al. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation 2014;129:28–41.[OpenUrl][1][Abstract/FREE Full Text][2] The importance of smoking cessation in the prevention and management of cardiovascular disease cannot be overestimated. Exposure to tobacco products, beginning in utero, causes substantial damage to vascular health, imposing dramatic public and personal health burdens over a… Expand
1 Citations


Cardiovascular Events Associated With Smoking Cessation Pharmacotherapies: A Network Meta-Analysis
Smoking cessation therapies do not appear to raise the risk of serious cardiovascular disease events, and the use of cessation medications is recommended to increase the likelihood of quitting. Expand
Managing tobacco use: the neglected cardiovascular disease risk factor.
An evidence-based approach for physicians is to routinely ask all patients about smoking status and SHS exposure, advise all smokers to quit and all patients to adopt smoke-free policies for their home and car, and offer all smokers in the office or hospital brief counselling, smoking cessation pharmacotherapy, and referral to local programmes where psychosocial support can be sustained in person or by telephone. Expand
Smoking cessation: primacy in cardiovascular disease prevention.
  • A. Pipe
  • Medicine
  • Current opinion in cardiology
  • 2008
Irrespective of this, it is increasingly clear that the provision of ‘best-practice’ smoking cessation approaches should be seen as part of a fundamental standard of care provided to nicotine-addicted patients in all cardiac settings. Expand
Smoking cessation and the cardiovascular specialist: Canadian Cardiovascular Society position paper.
It is the view of the Canadian Cardiovascular Society that all patients in every medical setting should have their smoking status systematically identified and documented and be offered specific assistance in initiating a cessation attempt. Expand
Smoking cessation for hospitalized smokers: an evaluation of the "Ottawa Model".
  • R. Reid, K. Mullen, +5 authors A. Pipe
  • Medicine
  • Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
  • 2010
The Ottawa Model for Smoking Cessation was successfully implemented in 9 hospitals leading to significantly higher long-term cessation rates and was more likely to accomplish counseling for smokers than delivery of medications or postdischarge follow-up. Expand
Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment.
  • N. Benowitz
  • Medicine
  • Progress in cardiovascular diseases
  • 2003
The information on the pathophysiology of smoking and cardiovascular disease is integrated and the implications of pathophysiologic mechanisms for the treatment of smokers with cardiovascular disease are discussed. Expand
Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics.
  • N. Benowitz
  • Medicine
  • Annual review of pharmacology and toxicology
  • 2009
Genetic studies indicate roles for nicotinic receptor subtypes, as well as genes involved in neuroplasticity and learning, in development of dependence, and Pharmacotherapeutic approaches to tobacco addiction include nicotine replacement, bupropion, and varenicline. Expand
New evidence that cigarette smoking remains the most important health hazard.
Both articles review mortality trends over time for men and women according to smoking status, and both confirm that smoking remains a huge threat to the public's health. Expand
Global effects of smoking, of quitting, and of taxing tobacco.
The magnitude of the disease burden from cigarette smoking worldwide and strategies to limit smoking are reviewed. Expand